Clinicopathologic characteristics and treatment outcomes of hepatoid adenocarcinoma of the stomach, a rare but unique subtype of gastric cancer
<p>Abstract</p> <p>Background</p> <p>Gastric hepatoid adenocarcinoma (HAC) is a special type of gastric cancer that morphologically mimics hepatocellular carcinoma. In this study, we performed an evaluation of clinicopathologic characteristics, treatment outcome, and pr...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2011-05-01
|
| Series: | BMC Gastroenterology |
| Subjects: | |
| Online Access: | http://www.biomedcentral.com/1471-230X/11/56 |
| _version_ | 1818081173174222848 |
|---|---|
| author | Oh Do-Youn Han Sae-Won Baek Sun Im Seock-Ah Kim Tae-You Bang Yung-Jue |
| author_facet | Oh Do-Youn Han Sae-Won Baek Sun Im Seock-Ah Kim Tae-You Bang Yung-Jue |
| author_sort | Oh Do-Youn |
| collection | DOAJ |
| description | <p>Abstract</p> <p>Background</p> <p>Gastric hepatoid adenocarcinoma (HAC) is a special type of gastric cancer that morphologically mimics hepatocellular carcinoma. In this study, we performed an evaluation of clinicopathologic characteristics, treatment outcome, and prognosis in patients with gastric HAC.</p> <p>Methods</p> <p>We consecutively enrolled patients with pathologically proven gastric HAC at Seoul National University Hospital between January 1996 and December 2008 and conducted a retrospective review. Among 15,253 patients with gastric cancer, 26 patients (0.17%) were diagnosed as gastric HAC.</p> <p>Results</p> <p>Among 26 patients, 22 were male and the median age was 63. Stage at diagnosis was stage IB in 3 patients, stage II in 6 patients, stage III in 7 patients, and stage IV in 10 patients. Eight patients out of 18 patients with stage IB, II, III, and IV relapsed after curative surgery. Relapse-free survival for these patients was 16.67 months. The most common metastatic site was intraabdominal lymph nodes (n = 9), followed by the liver (n = 8). Thirteen patients received palliative chemotherapy. The most commonly used regimen was a combination of fluoropyrimidine and platinum. Partial response was observed in one patient and stable disease in 5 patients. Median overall survival and progression free survival of these patients were 8.03 (95% CI: 6.59-9.47) and 3.47 months (95% CI: 0.65-6.29), respectively.</p> <p>Conclusions</p> <p>Gastric HAC is a very rare but unique type of stomach cancer. Early detection of this type of cancer is of critical importance to patient prognosis. Additional studies to reveal the biology of this tumor are warranted.</p> |
| first_indexed | 2024-12-10T19:01:59Z |
| format | Article |
| id | doaj.art-a86bab0d3c2a47319df9fbc3ecb64f21 |
| institution | Directory Open Access Journal |
| issn | 1471-230X |
| language | English |
| last_indexed | 2024-12-10T19:01:59Z |
| publishDate | 2011-05-01 |
| publisher | BMC |
| record_format | Article |
| series | BMC Gastroenterology |
| spelling | doaj.art-a86bab0d3c2a47319df9fbc3ecb64f212022-12-22T01:36:59ZengBMCBMC Gastroenterology1471-230X2011-05-011115610.1186/1471-230X-11-56Clinicopathologic characteristics and treatment outcomes of hepatoid adenocarcinoma of the stomach, a rare but unique subtype of gastric cancerOh Do-YounHan Sae-WonBaek SunIm Seock-AhKim Tae-YouBang Yung-Jue<p>Abstract</p> <p>Background</p> <p>Gastric hepatoid adenocarcinoma (HAC) is a special type of gastric cancer that morphologically mimics hepatocellular carcinoma. In this study, we performed an evaluation of clinicopathologic characteristics, treatment outcome, and prognosis in patients with gastric HAC.</p> <p>Methods</p> <p>We consecutively enrolled patients with pathologically proven gastric HAC at Seoul National University Hospital between January 1996 and December 2008 and conducted a retrospective review. Among 15,253 patients with gastric cancer, 26 patients (0.17%) were diagnosed as gastric HAC.</p> <p>Results</p> <p>Among 26 patients, 22 were male and the median age was 63. Stage at diagnosis was stage IB in 3 patients, stage II in 6 patients, stage III in 7 patients, and stage IV in 10 patients. Eight patients out of 18 patients with stage IB, II, III, and IV relapsed after curative surgery. Relapse-free survival for these patients was 16.67 months. The most common metastatic site was intraabdominal lymph nodes (n = 9), followed by the liver (n = 8). Thirteen patients received palliative chemotherapy. The most commonly used regimen was a combination of fluoropyrimidine and platinum. Partial response was observed in one patient and stable disease in 5 patients. Median overall survival and progression free survival of these patients were 8.03 (95% CI: 6.59-9.47) and 3.47 months (95% CI: 0.65-6.29), respectively.</p> <p>Conclusions</p> <p>Gastric HAC is a very rare but unique type of stomach cancer. Early detection of this type of cancer is of critical importance to patient prognosis. Additional studies to reveal the biology of this tumor are warranted.</p>http://www.biomedcentral.com/1471-230X/11/56Gastric hepatoid adenocarcinomatreatment outcomeprognosisclinicopathologic |
| spellingShingle | Oh Do-Youn Han Sae-Won Baek Sun Im Seock-Ah Kim Tae-You Bang Yung-Jue Clinicopathologic characteristics and treatment outcomes of hepatoid adenocarcinoma of the stomach, a rare but unique subtype of gastric cancer BMC Gastroenterology Gastric hepatoid adenocarcinoma treatment outcome prognosis clinicopathologic |
| title | Clinicopathologic characteristics and treatment outcomes of hepatoid adenocarcinoma of the stomach, a rare but unique subtype of gastric cancer |
| title_full | Clinicopathologic characteristics and treatment outcomes of hepatoid adenocarcinoma of the stomach, a rare but unique subtype of gastric cancer |
| title_fullStr | Clinicopathologic characteristics and treatment outcomes of hepatoid adenocarcinoma of the stomach, a rare but unique subtype of gastric cancer |
| title_full_unstemmed | Clinicopathologic characteristics and treatment outcomes of hepatoid adenocarcinoma of the stomach, a rare but unique subtype of gastric cancer |
| title_short | Clinicopathologic characteristics and treatment outcomes of hepatoid adenocarcinoma of the stomach, a rare but unique subtype of gastric cancer |
| title_sort | clinicopathologic characteristics and treatment outcomes of hepatoid adenocarcinoma of the stomach a rare but unique subtype of gastric cancer |
| topic | Gastric hepatoid adenocarcinoma treatment outcome prognosis clinicopathologic |
| url | http://www.biomedcentral.com/1471-230X/11/56 |
| work_keys_str_mv | AT ohdoyoun clinicopathologiccharacteristicsandtreatmentoutcomesofhepatoidadenocarcinomaofthestomachararebutuniquesubtypeofgastriccancer AT hansaewon clinicopathologiccharacteristicsandtreatmentoutcomesofhepatoidadenocarcinomaofthestomachararebutuniquesubtypeofgastriccancer AT baeksun clinicopathologiccharacteristicsandtreatmentoutcomesofhepatoidadenocarcinomaofthestomachararebutuniquesubtypeofgastriccancer AT imseockah clinicopathologiccharacteristicsandtreatmentoutcomesofhepatoidadenocarcinomaofthestomachararebutuniquesubtypeofgastriccancer AT kimtaeyou clinicopathologiccharacteristicsandtreatmentoutcomesofhepatoidadenocarcinomaofthestomachararebutuniquesubtypeofgastriccancer AT bangyungjue clinicopathologiccharacteristicsandtreatmentoutcomesofhepatoidadenocarcinomaofthestomachararebutuniquesubtypeofgastriccancer |